In 2016, the USPTO launched the Patents 4 Patients program to support the $1 billion National Cancer Moonshot initiative. In September of this year, the USPTO announced that the pilot program would be extended through January 31, 2023.
The United States Patent and Trademark Office (USPTO) and the World Intellectual Property Association (WIPO) have announced a partnership to facilitate the resolution of disputes related to standard essential patents (SEPs).
Finding an IP firm with experience claiming foreign priority is critical for companies based in or working in foreign markets. Here, we rank the top firms for foreign priority applications, based on volume.
Preparing information disclosure statements is a headache for most IP teams, but it doesn’t have to be. Automating your IDS process speeds up your workflow, ensures information integrity, and protects your most valuable support staff from burnout.
We are nearing the halfway point of 2022, with a new director at the USPTO, another opportunity to clarify the §101 patent eligibility framework, and a pair of bills poised to innovate the semiconductor industry. Here’s what you need to know about the year in patents so far.